| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/31/2004 | CN1486182A Medicinal compositions |
| 03/31/2004 | CN1486180A Methods for treating neuropsychiatric disorders with NMDA receptor antagonists |
| 03/31/2004 | CN1486179A Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 03/31/2004 | CN1486178A Histamine receptor antagonists |
| 03/31/2004 | CN1486177A Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 03/31/2004 | CN1485093A Compound acyeterion - metoclopramide preparation |
| 03/31/2004 | CN1143852C Ideno-, haphto- and benzocyclohepta dihydrothizole derivatives, the production thereof and their use as anorectic medicaments |
| 03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
| 03/31/2004 | CN1143618C Precise efficiency assay methods for active agents including chemotherapeutic agents |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713508 Such as 7-(3-(3-trifluoromethyl-7-propyl-6-benz-(4,5)-isoxazoloxy)propoxy)-2 -ethylchromane-2-carboxylic acid which are potent agonists of peroxisome proliferator activated receptor |
| 03/30/2004 | US6713489 Treatment of atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or syndrome x |
| 03/30/2004 | US6713467 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer |
| 03/30/2004 | US6713463 Methods and compositions for treating and preventing mucositis |
| 03/30/2004 | US6713462 Quinolinones and uses thereof |
| 03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
| 03/30/2004 | US6713276 Modulation of Aβ levels by β-secretase BACE2 |
| 03/30/2004 | US6713268 Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation |
| 03/30/2004 | US6713247 Human CNS cell lines and methods of use therefor |
| 03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
| 03/30/2004 | US6713074 Cosmetic composition and method |
| 03/30/2004 | US6713065 Methods of using hedgehog proteins to modulate hematopoiesis and vascular growth |
| 03/30/2004 | US6713056 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 03/30/2004 | US6712617 Methods of preventing UVB-induced skin damage |
| 03/30/2004 | CA2330217C Therapeutic agent for a cancer and method of screening the same and health-care auxiliary food |
| 03/30/2004 | CA2136233C Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 03/30/2004 | CA2117321C Stable cosmetic or dermatologic oil-in-water emulsion composition containing at least one vegetable oil comprising at least 40 % of linoleic acid triglycerides |
| 03/25/2004 | WO2004025270A2 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
| 03/25/2004 | WO2004025256A2 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | WO2004024952A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | WO2004024919A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | WO2004024896A2 Phenyl-indole compounds |
| 03/25/2004 | WO2004024884A2 Syts as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | WO2004024883A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024882A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024880A2 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024879A2 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 03/25/2004 | WO2004024197A1 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 03/25/2004 | WO2004024186A2 Treatment of cyclooxygenase-3 mediated diseases and disorders |
| 03/25/2004 | WO2004024169A1 Composition comprising an abrasive agent for treating insect bites |
| 03/25/2004 | WO2004024165A1 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor |
| 03/25/2004 | WO2004024163A1 Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines |
| 03/25/2004 | WO2004024151A1 Composition and potentiating method |
| 03/25/2004 | WO2004024140A1 Efflux pump inhibitors |
| 03/25/2004 | WO2004024130A2 TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE |
| 03/25/2004 | WO2004024097A2 Compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024095A2 ß-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES |
| 03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024070A2 Factors that bind intestinal toxins |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004023984A2 Novel composition and method for treatment of upper respiratory conditions |
| 03/25/2004 | WO2004023899A1 Human and/or animal fiber-water including encapsulated additives having specific dietary and medical uses |
| 03/25/2004 | WO2004023889A2 Full range nutritional supplements from plant materials and methods for their manufacture |
| 03/25/2004 | WO2004014367A3 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2004000849A3 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 03/25/2004 | WO2004000801A3 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 03/25/2004 | WO2003105780A3 A dry powder oligonucleotide formulation, preparation and its uses |
| 03/25/2004 | WO2003105752A3 Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate) |
| 03/25/2004 | WO2003103822A3 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 03/25/2004 | WO2003103676A3 Method of treating cancer using kinase inhibitors |
| 03/25/2004 | WO2003101434A3 Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| 03/25/2004 | WO2003098992A3 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 03/25/2004 | WO2003092624A3 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 03/25/2004 | WO2003092610A3 Methods of using cytokine antagonists to treat hiv infection and aids |
| 03/25/2004 | WO2003086372A3 Methods of treating medication-, substance-, disease-, and other medical condition-related sexual dysfunction |
| 03/25/2004 | WO2003082283A3 Pharmaceutical composition with combined active agents and methods for using the same |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003082186A3 Use of benzimidazole analogs in the treatment of cell proliferation |
| 03/25/2004 | WO2003080070A3 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
| 03/25/2004 | WO2003077949A3 Methods of treating diabetes using pde 11a inhibitors |
| 03/25/2004 | WO2003075746A3 Methods for aneurysm repair |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003059372A3 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 03/25/2004 | WO2003059266A3 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs |
| 03/25/2004 | WO2003055443A3 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003046578A3 Method for the assessment and prognosis of sarcoidosis |
| 03/25/2004 | WO2003043613A3 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/25/2004 | WO2003039519A3 Dual controlled release dosage form |
| 03/25/2004 | WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor |
| 03/25/2004 | WO2003037361A3 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003028633A3 Parenteral delivery systems |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003015612A3 Materials and methods to promote repair of nerve tissue |
| 03/25/2004 | WO2003014745A3 Method for identifying anti-inflammatory drugs |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2003011008A3 Therapeutic delivery compositions and methods of use thereof |
| 03/25/2004 | WO2003000343A3 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002074290B1 Dermatological preparations containing a nsaid |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002066044A3 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |